Remove DNA Remove RNA Remove Science
article thumbnail

An ancient RNA-guided system could simplify delivery of gene editing therapies

Broad Institute

An ancient RNA-guided system could simplify delivery of gene editing therapies By Corie Lok February 27, 2025 Breadcrumb Home An ancient RNA-guided system could simplify delivery of gene editing therapies The programmable proteins are compact, modular, and can be directed to modify DNA in human cells. Lisa Yang and Hock E.

RNA 66
article thumbnail

NGS is evolving: collaboration and tech lead the way

Drug Target Review

Several strategic partnerships formed by Beckman Coulter Life Sciences illustrate how cooperative models and an open‐chemistry approach facilitating advances in genomics research. Pillar and Beckman Coulter Life Sciences tested a 22‐gene panel for solid tumour testing, comparing the automated NGS workflow with a manual process.

RNA 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The next phase of the multiomics evolution, powered by AI

Drug Target Review

The dynamic behaviour of RNA transcripts, the regulation and modification of proteins, the lipid composition of membranes, the structural organisation of cells and the spatial context of tissues all play critical roles in disease progression and therapeutic response.

RNA 72
article thumbnail

New tRNA tech aims to rewrite rare disease treatment

Drug Target Review

One company leading the charge in this revolution is Alltrna , whose pioneering work in engineered transfer RNA (tRNA) therapeutics is offering new hope for patients with rare genetic diseases. A single tRNA therapeutic could treat multiple diseases caused by the same mutation.”

Disease 80
article thumbnail

Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management

LifeSciVC

Founding Vision: Harnessing RNA Editing for Transformative Medicine Korro Bio’s story began in 2018, co-founded by a remarkable group: Jean-François Formela, M.D. Academic specializing in RNA editing). Their collective expertise—spanning gene editing, venture creation, and foundational science—set the stage for building Korro.

RNA 67
article thumbnail

What single cells are revealing about brain disorders

Drug Target Review

From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I I took a couple of other software startup opportunities,” he adds, “but I realised I missed the genomics and science. I did physics and math as an undergraduate,” he explains. I started looking around and getting interested in biology.

article thumbnail

Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig

Alta Sciences

From groundbreaking science to next-gen technologies, the energy at this year’s conference was undeniable. Curious to see the science in action? What started 28 years ago as a meeting for academic researchers has evolved into a dynamic, cross-disciplinary hub for the entire cell and gene therapy ecosystem.